Xtl Biopharmaceuticals XTLB
NASDAQ XTLB
$2.33 +0.12 (+5.49%)
As of: Sep 30, 2026 · 11:49 AM EDT

Xtl Biopharmaceuticals (XTLB) Income - Equity (2009 - 2013)

Updated

Xtl Biopharmaceuticals (XTLB) reported Income - Equity of $445,000 for the quarter ended Sep 30, 2013, compared with -$150,000 a year earlier.

Analysis

Xtl Biopharmaceuticals (XTLB) Income - Equity (2009 - 2013) Analysis & Trends

Over the twelve months ended Sep 30, 2013, Xtl Biopharmaceuticals' Income - Equity came in at -$543,000; for the year ended Dec 31, 2012, it was -$1.74 million.

  • By year, Income - Equity came in at $2.59 million in the year ended Dec 31, 2009.
  • The figure for the quarter ended Sep 30, 2013 ranks as the highest quarterly Income - Equity since the quarter ended Jun 30, 2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income - Equity (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Xtl Biopharmaceuticals 2.11 Bn 2.11 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2013 445,000.00
Dec 31, 2012 -548,000.00
Sep 30, 2012 -150,000.00
Sep 30, 2010 -290,000.00
Jun 30, 2010 -316,000.00
Dec 31, 2009 -288,000.00
Sep 30, 2009 9,000.00
Jun 30, 2009 1.21 Mn
API Access

Xtl Biopharmaceuticals Income - Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-equity&ticker=XTLB&period=max&api_key=YOUR_API_KEY